Protocols
2 protocol(s) meet the specified criteria
Drug: DARATUMUMAB
Protocol No.TitleStatus
54767414SMM3001A Phase 3 Randomized, Multicenter Study of Subcutaneous Daratumumab Versus Active Monitoring in Subjects with High-risk Smoldering Multiple MyelomaOpen
KCP-330-017STOMPKCP-330-017 STOMP A Phase 1b/2 Study of Selinexor (KPT-330) in Combination with Backbone Treatments for Relapsed/Refractory Multiple MyelomaOpen